{"fname":"Ryan", "lname":"Larry", "email":"Ryan.Larry123@yopmail.com", "mobile_number":"+919082416533", "home_number":"", "dob":"1988-08-15", "gender":"Male", "address1":"Park1", "address2":"Greenfield", "address3":"Unit-22", "zip":"10001", "city":"New York", "state":"NY", "country":"US", "county":"New York", "ethnicity":"Hispanic or Latino", "races":["American Indian", "Alaska Native"], "countryFlag":{"name":"India (भारत)", "iso2":"in", "dial_code":"+91"}, "static_questionnaire_answers":[{"question_id":"3", "question_text":"Insurance", "answers":["Insw11"]}, {"question_id":"4", "question_text":"Insurance Provider Name", "answers":["Prv11"]}, {"question_id":"5", "question_text":"Medical Group Number", "answers":["MGN4871"]}, {"question_id":"6", "question_text":"Medical ID", "answers":["MID9651"]}, {"question_id":"1", "question_text":"Which of the following best describes your ethnic group? *", "answers":["Hispanic or Latino"]}, {"question_id":"2", "question_text":"Which of the following best describes your race? Please select all that apply? *", "answers":["American Indian", "Alaska Native"]}, {"question_id":"12", "question_text":" Have you ever had any of the following medical conditions? - Asthama(moderate to severe) - Cancer - Cerebrovascular disease - Chronic Kidney Disease - Chronic obstructive pulmonary disease (COPD) - Cystic fibrosis - Down Syndrome - Heart conditions, such as coronary artery disease or cardiomyopathies - Hypertension or high blood pressure - Immunocompromised state (weakened immune system) - Liver disease - Neurologic conditions, (such as dementia) - Nicotine/smoking addiction - Obesity - Overweight - Pulmonary fibrosis (damaged or scarred lung tissues) - Sickle cell disease - Thalassemia (type of blood disorder) - Type 1 diabetes mellitus - Type 2 diabetes mellitus.", "answers":["No"]}, {"question_id":"7", "question_text":"Select all that apply", "answers":["I work in a patient-facing healthcare setting or a congregate living setting.", "Responder or Support Staff for First Responder Agency."]}, {"question_id":"8", "question_text":"Prescription, over-the- counter medications, dietary supplements, or herbal remedies being taken at the time of Vaccination.", "answers":[]}, {"question_id":"9", "question_text":"Allergies to medications, food, or other products:", "answers":["No allg"]}, {"question_id":"10", "question_text":"Other illnesses at the time of vaccination and up to one month", "answers":[]}, {"question_id":"11", "question_text":"Chronic or long-standing health conditions prior", "answers":["No chronic"]}], "medical_condition":"No", "employment_types":["I work in a patient-facing healthcare setting or a congregate living setting.", "Responder or Support Staff for First Responder Agency."], "is_activated":false, "registered_date":"2021-10-11", "registered_by_id":"f82d5a8b-a37c-4ef7-af7e-e495ae3bb9f1", "id":"525db6c7-220d-4e43-969b-ac9a1747139a", "is_active":true, "create_time":"2021-10-11T10:39:47.479Z", "modify_time":"2021-10-11T11:12:20.386Z", "concatenated_races":"American Indian, Alaska Native", "modified_by_id":"4fecea6f-f2da-4568-900f-e766d12f5d50", "modified_by_admin_time":"2021-10-11T11:11:00.440Z", "recipient_facts":[{"RecipientFact":{"material_id":"08756daa-e635-4609-bf06-e14c7a6f2a6b", "material_category_id":"865ab47e-fab1-4871-98e7-5306c013ec10", "material_batch_id":"902ba958-007f-4e96-b438-9a7dec44aea0", "batch_no":"MOD002", "dose_in_series":1, "dose_date":"2021-10-11T10:52:26.831Z", "status":"completed", "visit_id":"f9973e27-56de-4832-bedb-7050c795c466", "site_id":"f8d1dba3-81fb-4748-852f-5ce1cbd7411a", "ticket_number":"GPYQLS"}}, {"RecipientFact":{"material_id":"08756daa-e635-4609-bf06-e14c7a6f2a6b", "material_category_id":"865ab47e-fab1-4871-98e7-5306c013ec10", "material_batch_id":"902ba958-007f-4e96-b438-9a7dec44aea0", "batch_no":"MOD002", "dose_in_series":2, "dose_date":"2021-11-08T11:57:38.490Z", "status":"completed", "visit_id":"84ff0927-d926-42af-8440-aecefaad1808", "site_id":"f8d1dba3-81fb-4748-852f-5ce1cbd7411a", "ticket_number":"IBPSA8"}}, {"RecipientFact":{"material_id":"08756daa-e635-4609-bf06-e14c7a6f2a6b", "material_category_id":"865ab47e-fab1-4871-98e7-5306c013ec10", "material_batch_id":"902ba958-007f-4e96-b438-9a7dec44aea0", "batch_no":"MOD002", "dose_in_series":3, "dose_date":"2021-12-02T12:04:11.380Z", "status":"completed", "visit_id":"b47be6a8-cdb8-42c9-9eff-49b86f4ba728", "site_id":"f8d1dba3-81fb-4748-852f-5ce1cbd7411a", "ticket_number":"JVOJ5C"}}, {"RecipientFact":{"material_id":"02aee235-8a59-41a5-80c8-2a645f75ca01", "material_category_id":"865ab47e-fab1-4871-98e7-5306c013ec10", "material_batch_id":"c997b292-59d2-4541-ad60-1bd984c3ebd3", "batch_no":"ModBost15", "dose_in_series":4, "dose_date":"2021-12-12T12:11:55.165Z", "status":"completed", "visit_id":"fba8f5c8-eb47-4d9d-a76e-556abaa482a3", "site_id":"f8d1dba3-81fb-4748-852f-5ce1cbd7411a", "ticket_number":"K1MV74"}}], "administered_doses":["08756daa-e635-4609-bf06-e14c7a6f2a6b_DOSE_1", "08756daa-e635-4609-bf06-e14c7a6f2a6b_DOSE_2", "08756daa-e635-4609-bf06-e14c7a6f2a6b_DOSE_3", "02aee235-8a59-41a5-80c8-2a645f75ca01_DOSE_4"]}